Rangers and Ian Kinsler agree to five-year, $75 million contract extension

12 Comments

Ian Kinsler said last week that he was “disappointed” that a contract extension with the Rangers wouldn’t get done by Opening Day, but the two sides were apparently able to bridge the gap over the past couple of days.

According to Jeff Wilson of the Fort Worth Star-Telegram, the Rangers and Kinsler have agreed to a five-year extension with an option for a sixth year. An official announcement is expected Tuesday.

Kinsler himself confirmed reports of the deal and added that it’s worth $75 million guaranteed, $5 million of which is a buyout on the option year. The deal kicks in next season, replacing the option year on his existing contract, and will keep him with the club through 2017 and possibly 2018.

Kinsler’s new deal will have an AAV (average annual value) of $15 million per season, which tops Dan Uggla ($12.4 million) for the highest among second baseman. However, it falls just under Chase Utley’s seven-year, $85 million contract in total value.

Kinsler, a two-time All-Star, owns a .276/.356/.470 batting line in the big leagues. The 29-year-old appeared in a career-high 155 games last season while batting .255/.355/.477 with 32 homers, 77 RBI, 30 stolen bases and an .832 OPS.

Ronald Acuña’s CT scan comes back clean

Getty Images
4 Comments

The Braves announced late this morning that the CT scan on Ronald Acuña’s left elbow came back clear and he is considered day-to-day.

As you have all heard by now, Acuña was pulled from Wednesday night’s game against the Marlins after taking a Jose Urena pitch off his elbow in the bottom of the first inning in what was quite obviously an intentional plunking. Acuña  only suffered a bruise and some swelling. He missed all but that at bat of last night’s game and will likely sit out tonight’s game against the Rockies. It is expected that he’ll be back in action this weekend, however.

Acuña is batting .358/.425/.821 with 12 home runs, 24 RBI, and 25 runs scored over his last 25 games.